Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIGMS NIH HHS
Grant: U54 GM115458
NIGMS NIH HHS
Grant: P20 GM103548
NCI NIH HHS
Grant: P30 CA042014
NICHD NIH HHS
Grant: R25 HD097633
NCI NIH HHS
Grant: R01 CA180033
National Institutes of Health
Grant: 3U54GM115458-07S2
Great Plains IDeA-CTR
National Institutes of Health
Grant: 5R01CA180033-02
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
National Institutes of Health
Grant: 5P20GM103548-03
Center for Cancer Biology Research
National Institutes of Health
Grant: 3P30CA042014-30S2
Cancer Center Support Grant
FWCI
0.56
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals